Clinical trial
Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic…
NCT00003764 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003764 |
|---|---|
| Title | Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia |
| Official title | Phase III Randomized Trial of Fludarabine and Cyclophosphamide Versus Fludarabine for Previously Untreated Chronic Lymphocytic Leukemia |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH Cancer and Leukemia Group B SWOG Cancer Research Network |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug |
| Interventions | cyclophosphamide, fludarabine phosphate |
| Enrollment | 280 |
| Start date | Mar 9, 2000 |
| Primary completion | Nov 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 18, 2023 |
| Countries | Canada, Puerto Rico, South Africa, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: